Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Diabetes Care 31:S222-S225, 2008
DOI: 10.2337/dc08-s253
© 2008 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wienbergen, H.
Right arrow Articles by Gitt, A. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wienbergen, H.
Right arrow Articles by Gitt, A. K.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Section II: Diabetes Complications and Hypertension-Novel Insights into Pathophysiology and Management
Original Article

Should We Prescribe Statin and Aspirin for Every Diabetic Patient?

Is it time for a polypill?

Harm Wienbergen, MD, Jochen Senges, MD, PHD, FESC, FACC and Anselm K. Gitt, MD, FESC

From the Institut für Herzinfarktforschung an der Universität Heidelberg, Klinikum Ludwigshafen, Ludwigshafen, Germany

Address correspondence and reprint requests to Anselm K. Gitt, Institut für Herzinfarktforschung an der Universität Heidelberg, c/o Klinikum Ludwigshafen, Bremserstraβe 79, 67063 Ludwigshafen, Germany. E-mail: gitta@klilu.ed

The first 300 words of the full text of this article appear below.


   INTRODUCTION
 
There is clear evidence that diabetic patients constitute a group at high cardiovascular risk. Epidemiologic data show that with the aging of the European population, the percentage of diabetic patients will increase in the upcoming years, with important consequences for cardiovascular mortality. Therefore, the question arises, "How aggressive should prevention with statins and aspirin in diabetic patients be?"

As several studies have demonstrated, cardiovascular mortality of diabetic patients is as high as in nondiabetic patients with known coronary artery disease (1–3); thus, the term "coronary artery disease risk equivalent" has been introduced.

A coronary artery disease risk equivalent implicates the need for stronger treatment goals of secondary prevention for cardiovascular risk factors. A further debate is whether medical treatment provided to patients with coronary heart disease should also be given to diabetic patients without known coronary heart disease.


   ASPIRIN—
 
Aspirin administration as secondary prevention in coronary heart disease is well established. The beneficial effect of aspirin therapy in secondary prevention of coronary heart disease has been demonstrated by the meta-analysis of the Antithrombotic Trialist’ Collaboration in 2002, with a total relative risk reduction of 15% for cardiovascular death and of 28% for nonfatal re-infarction (4) (Fig. 1).


Figure Removed (Available Only in the Full Text)
View larger version (38K):



  		Figure 1— Beneficial effect of aspirin in secondary coronary prevention. Adapted from Antithrombotic Trialists’ Collaboration (4). *Vascular events: death from vascular causes, nonfatal myocardial infarction, and nonfatal stroke. MI, myocardial infarction; pts., patients; TIA, transient ischemic attack.

 
Regarding primary prevention, Ridker et al. (5) showed a risk reduction by aspirin of 26% for a first cardiovascular event in women ≥65 years of age. In a meta-analysis of primary prevention, Patrono et al. (6) demonstrated that with increasing cardiovascular risk, the benefit of aspirin therapy increases without an increase of bleeding complications; the . . . [Full Text of this Article]


   STATINS—
 

   COMBINATION OF DRUGS—
 

   CONCLUSIONS—
 

Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2008 by the American Diabetes Association.